21411 ⎘
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy Purification or manufacturing processes for gene therapy compositions
Delivery of nucleic acid-like compounds
#302Long lasting drug formulations
#303DNA origami devices
#304ENVIRONMENTALLY-RESPONSIVE NANOCOMPOSITES AND METHODS OF THEIR USE
#305Transduction efficiency, capsid-modified rAAV vectors and methods of use
#306Scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
#307PROCESS FOR PREPARING PURIFIED NUCLEIC ACID AND THE USE THEREOF
#308IMMORTALIZED AVIAN CELL LINES FOR VIRUS PRODUCTION
#309TREATMENT OF EYE DISEASES USING ENCAPSULATED CELLS ENCODING AND SECRETING A NEUROPROTECTIVE FACTOR AND/OR AN ANTI-ANGIOGENIC FACTOR
#310APTAMER-TARGETED SIRNA TO INHIBIT NONSENSE MEDIATED DECAY
#311Bovine adeno-associated viral (BAAV) vector and uses thereof
#312Treatment of Alopecia By Micropore Delivery of Stem Cells
#313Viral Vectors with Improved Properties
#314Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
#315Freeze-dried product for introducing nucleic acid, oligonucleic acid or derivative thereof
#316Long lasting drug formulations
#317Recombinant influenza viruses for vaccines and gene therapy
#318NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF
#319COMPOSITIONS, KITS AND METHODS FOR IN VITRO ANTIGEN PRESENTATION, ASSESSING VACCINE EFFICACY, AND ASSESSING IMMUNOTOXICITY OF BIOLOGICS AND DRUGS
#320COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#321Use of common γ chain cytokines for the visualization, isolation and genetic modification of memory T lymphocytes
#322Recombinant influenza vectors with tandem transcription units
#323PROCESS FOR PREPARING PURIFIED NUCLEIC ACID AND THE USE THEREOF
#324PROCESS FOR PLASMID DNA FERMENTATION
#325Engineered cells expressing multiple immunomodulators and uses thereof
#326MATERIALS AND METHODS OF INTRODUCING GENETIC MATERIAL INTO LIVING CELLS
#327Generation of replication competent viruses for therapeutic use
#328RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#329METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF GENE THERAPEUTIC VECTORS
#330Non-Aggregating Virus Formulation
#331Compositions and methods relating to DNA-based particles
#332Recombinant MVA virus and the use thereof
#333Porcine adeno-associated viruses
#334Recombinant MVA virus
#335METHODS FOR GENERATING HIGH TITER HELPER-FREE PREPARATIONS OF RELEASED RECOMBINANT AAV VECTORS
#336Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
#337METHOD FOR PRODUCING ADENOVIRUS VECTORS FOR GENE THERAPY AND DNA SEQUENCES USED THEREFOR
#338Tyrosine-modified recombinant rAAV vector compositions and methods for use
#339PROCESS FOR PREPARING PURIFIED NUCLEIC ACID AND THE USE THEREOF
#340METHOD OF PROTECTING SENSITIVE MOLECULES FROM A PHOTO-POLYMERIZING ENVIRONMENT
#341Production of Lentiviral Vectors
#342Virus purification
#343Retroviral vectors
#344Scalable production method for AAV
#345RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#346CELLS FOR ADENOVIRUS VECTOR AND PROTEIN PRODUCTION
#347Generation of Replication Competent Viruses for Therapeutic Use
#348Method of increasing the function of an AAV vector
#349PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN
#350SYSTEM FOR RAPID PRODUCTION OF HIGH-TITER AND REPLICATION-COMPETENT ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS
#351DELIVERY OF NUCLEIC ACID-LIKE COMPOUNDS
#352Organ regeneration device
#353Freeze-Dried Product for Introducing Nucleic Acid, Oligonucleic Acid or Derivative Thereof
#354Compositions comprising viruses and methods for concentrating virus preparations
#355MICROENCAPSULATED MATERIALS AND METHOD OF MAKING SAME
#356METHOD FOR PRODUCING A NUCLEIC-ACID-CONTAINING COMPLEX PREPARATION
#357COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#358Treatment of alopecia by micropore delivery of stem cells
#359Immortalized avian cell lines for virus production
#360Cancer-targeted viral vectors
#361Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#362Compositions comprising viruses and methods for concentrating virus preparations
#363Packaging systems for human recombinant adenovirus to be used in gene therapy
#364Apparatus and Method For Electroporation of Biological Samples
#365Drug delivery system and method
#366Compositions Comprising Viruses and Methods for Concentrating Virus Preparations
#367Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy
#368Compositions comprising viruses and methods for concentrating virus preparations
#369Modified virus
#370Vector
#371Process for plasmid DNA fermentation
#372Methods for treating cancer using interferon-ω-expressing polynucleotides
#373Therapeutic methods for nucleic acid delivery vehicles
#374Method for purifying plasmid DNA
#375Heparin and heparan sulfate binding chimeric vectors
#376Liposomal assembly for therapeutic and/or diagnostic use
#377Method of preparation for pharmaceutical grade plasmid DNA
#378Methods and compositions for the Synthesis of RNA and DNA
#379Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
#380Retroviral vectors
#381Avian adenoassociated virus and uses thereof
#382Bovine adeno-associated viral (BAAV) vector and uses thereof
#383Recombinant MVA virus, and the use thereof
#384Recombinant MVA virus, and the use thereof
#385Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
#386Viral vectors with improved properties
#387High-titer retroviral packaging cells
#388Avoidance of undesirable replication intermediates in plasmid propagation
#389Packaging systems for human recombinant adenovirus to be used in gene therapy
#390Herpesvirus amplicon particles
#391Method of protecting sensitive molecules from a photo-polymerizing environment
#392Use of flexible bag containers for viral production
#393Recombinant influenza vectors with tandem transcription units
#394Process for preparing purified nucleic acid and the use thereof
#395Nucleic acid coated particles suitable for temporary storage
#396System producing infectious recombinant influenza virus
#397Generation of replication competent viruses for therapeutic use
#398Recombinant influenza viruses for vaccines and gene therapy
#399Chloroquine coupled nucleic acids and methods for their synthesis
#400Compositions comprising viruses and methods for concentrating virus preparations
#401Cancer - targeted viral vectors
#402Methods for generating high titer helper-free preparations of released recombinant AAV vectors
#403Packaging systems for human recombinant adenovirus to be used in gene therapy
#404Compositions comprising viruses and methods for concentrating virus preparations
#405Selective precipitation of viruses using polyectrolytes
#406Methods for purifying viral particles for gene therapy
#407Large scale methods of producing adenovirus and adenovirus seed stocks
#408Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
#409Methods for improving pancreatic islet cell transplantation
#410Continuous-flow method for preparing microparticles
#411Use of contact lens for corneal cell transplant
#412Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity